Proliferative Marker Ki 67.
A Clinicopathological Study of Ovarian Tumors and The Role of Immunohistochemical Proliferative Marker Ki 67.
... using Ki- 67 index is a simple method and has long been shown to have a prognostic value in a variety of malignancies like CNS tumors, Lymphoproliferative diseases, connective tissue tumors and breast ...
151
Peculiarities of changes in expression of Ki-67 proliferation marker by haematopoietic peripheral blood and bone marrow cells in patients with myelodysplastic syndrome
... the proliferative activity marker was observed in patients in the run-in period and in the disease ...proliferation marker expression in the disease progression (p < ...high proliferative ...
5
Proliferative potential in benign mixed salivary gland tumors, using Ki67 marker in relation to different clinicopathological parameters
... Concerning Ki67 labeling index score, analysis indicated that Ki-67 expression was weak (>5 and ≤ 25%) in nine cases (16.36%), all of them were of epithelial (cell–rich) subtype (Figures 3). They were ...
8
P63 and Ki-67 Expression in Dentigerous Cyst and Ameloblastomas
... analysed Ki-67 prolifera- tion marker in the samples and evaluated its LI in com- parison with ...ameloblastomas. Ki-67 LI did not show any significant different between dentiger- ous ...
6
Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas - an immunohistochemical study
... The caveats of immunohistochemical analyses include different antibodies, different antigens, background staining, and inhomogeneous staining that can contri- bute to interlaboratory and interobserver variations. Wrong ...
8
Evaluation of mouse enteroids as a model for Lawsonia intracellularis infection
... Lawsonia intracellularis, an obligate intracellular bacterium, is an important enteric pathogen in pig herds and horse farms worldwide. The hallmark feature of L. intracellularis infection is the proliferation of ...
11
Correlation between Choline Level Measured by Proton MR Spectroscopy and Ki 67 Labeling Index in Gliomas
... tumor proliferative ac- tivity or malignancy has a potentially significant impact on the therapeutic strategy for patients with brain ...a Ki-67 labeling index is a promising proliferation ...
7
Original Article Ki-67, CyclinD1 and P53 as expected new targets for pterygium treatment in clinical practice
... the proliferative capacity of ...the proliferative state of cells ...that Ki-67 can be used as a marker of breast cancer prolifera- tion ...on Ki-67, CyclinD1, and p53 are ...
10
Expression Analysis of p53, Ki 67 and bcl 2 in Pre Malignant Lesions of the Cervix
... Marker Ki-67 has been studied as an important tumor ...to proliferative action, lesion grade and HPV in several studies [40] ...found Ki-67 expression restricted to the basal ...
8
Clinico-pathological and radiological correlation of CNS tumors along with role of Ki 67 proliferative index in grading Astrocytoma and Meningiomas
... of proliferative activity are important in determining the grade and recurrence of the ...Astrocytomas. Ki 67 is a nuclear marker used to demonstrate proliferative phase of cell ...with ...
7
Efficacy of in vivo stainging in the early detection of oral potentially malignant and malignant disorders in comparison with expression of ki 67 proliferative marker
... of Ki-67 proliferative marker was high in severe dysplasia where the active multiplication of cells are taking place, moderate proliferation in moderate dysplasia and low proliferation in mild ...
8
Immunohistochemical detection of Hsp90 and Ki-67 in pterygium
... human Ki-67 protein is strictly associated with cell ...the Ki-67 pro- tein is present during all active phases of the cell cycle (G1, S, G2, and mitosis), but is absent from resting cells ...
7
Original Article Ki-67 expression of immunohistochemistry using computerized image analysis is a useful prognostic marker in follicular lymphomas
... assessed Ki-67 stained tissue sections of 15 FLs by both manual and auto- mated analysis and observed a good concor- dance between the two methods ...the Ki-67- positive area in IHC was ...the ...
9
<p>ACAT2 Promotes Cell Proliferation and Associates with Malignant Progression in Colorectal Cancer</p>
... Figure 5 Knockdown of ACAT2 expression suppresses CRC growth and inhibits Ki-67 expression in vivo. (A, B) The ef fi ciency of ACAT2 knockdown in CT26 cells was measured by qPCR and Western blotting. (C, D) ...
12
Metformin Induces Apoptosis and Alters Cellular Responses to Oxidative Stress in HT29 Colon Cancer Cells
... Confocal analysis of Ki-67 protein in treated and untreated cells with graded concentrations 103.. of metformin (blue: DAPI; green: Ki-67; C,F: merge).[r] ...
19
Click here to download PDF version of the article !
... high Ki-67 LI than benign and borderline tumours ...that Ki-67 LI was highest in malignant tumours (Mean PI – ...high Ki-67 LI in serous group and no correlation was found ...
5
Surgical delivery of drug releasing poly(lactic co glycolic acid)/poly(ethylene glycol) paste with in vivo effects against glioblastoma
... nescent marker were injected subcutaneously into the ani- mals ’ left flank and the tumour was grown for 15 days while monitored using the IVIS ® Spectrum bioluminescent imaging system (PerkinElmer, Cambridge, ...
7
Original Article Identification of hypomethylation profile of Ki-67 promoter in vitro and in vivo
... Concerning Ki-67 gene expression, our results showed that Ki-67 was highly expressed in nor- mal cell lines (HL-7702, ...fact, Ki-67 could also be detected in other normal cell ...
9
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study
... The Ki-67 protein is well known and widely used to assess the tumour proliferation ...shown Ki-67 to be a prognostic marker in prostate cancer treated by radical prostatectomy, but none ...
6
Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer.
... N0, Ki-67 B 2.7%) vs. non-0 assignments based on the CLIA Ki-67 assay deter- mined using the Kaplan–Meier ...on-treatment Ki-67 ( [ 10 vs B 10%) in the POL ...
10